CWP
GSK icon

Curated Wealth Partners’s GSK GSK Stock Holding History

Curated Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
+250,051
New +$13.2M 0.04% 423

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Curated Wealth Partners's GSK Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in GSK (GSK) in Q2 2026: 250,051 shares worth $291K. The stake represents 0.04% of the portfolio and ranks #423 among its holdings.

353 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Curated Wealth Partners held 250,051 shares of GSK worth $291K as of Q2 2026.
  • GSK was a new Curated Wealth Partners position in Q2 2026.
  • GSK made up 0.04% of Curated Wealth Partners's portfolio in Q2 2026, its #423 holding.
  • 353 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.